Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis.
Inagaki
Y
Y
Liver Fibrosis Research Unit, Department of Community Health, Tokai University School of Medicine, Bohseidai, Isehara 259-1193, Japan. yutakai@is.icc.u-tokai.ac.jp
Okazaki
I
I
D055419:Bone Morphogenetic Protein 7; D019485:Bone Morphogenetic Proteins / Q000235:genetics; D003094:Collagen / Q000235:genetics; D024042:Collagen Type I; D004791:Enzyme Inhibitors; D005786:Gene Expression Regulation / Q000235:genetics; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D007372:Interferons / Q000235:genetics; D008103:Liver Cirrhosis / Q000235:genetics* / Q000628:therapy; D020928:Mitogen-Activated Protein Kinases / Q000235:genetics; D015398:Signal Transduction / Q000235:genetics*; D051785:Smad Proteins / Q000235:genetics*; D016212:Transforming Growth Factor beta / Q000037:antagonists & inhibitors / Q000235:genetics*; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics
C525819:BMP7 protein, human; D055419:Bone Morphogenetic Protein 7; D019485:Bone Morphogenetic Proteins; D024042:Collagen Type I; D004791:Enzyme Inhibitors; D051785:Smad Proteins; D016212:Transforming Growth Factor beta; D014409:Tumor Necrosis Factor-alpha; D003094:Collagen; D007372:Interferons; D020928:Mitogen-Activated Protein Kinases